Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults [Phase 3]

View source ↗

Summary

A Phase 3 study comparing Stribild to ritonavir-boosted atazanavir plus Truvada in ART-naive adults with HIV-1 infection completed, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Ritonavir (Ritonavir)
• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2012-10-22